Gary Harvey is the President and CEO of Cirque Analytics, an economic, statistical, and financial consulting company headquartered in Jackson Hole, WY and with offices in California and Washington DC. He received the Bachelor of Science degree in Applied Mathematics from the United States Air Force Academy and the Master of Science degree in Operations Research from the Air Force Institute of Technology. While an officer in the U.S. Air Force he primarily analyzed U.S. force structure and weapon systems performance.He has served as an expert witness in litigation, arbitration, and regulatory proceedings involving evaluation of damages, commercial disputes, antitrust, sample design and analysis, payment card market analysis, payment card industry data analysis, TV broadcast data analysis, conjoint analysis, copyright infringement, patent infringement, consumer product performance, epidemiology, toxic tort analysis, insurance claims analysis, medical claims analysis, healthcare fraud claims analysis, victims of human trafficking, and class certification. Additionally, he has worked as a consultant on numerous litigation and business consulting engagements including: antitrust matters involving claims of price-fixing; matters involving claims of false advertising, unfair competition and monopolization, consumer product safety and performance, conjoint analysis, and environmental damage; class actions alleging disparate impact in insurance, insurance claims analysis, and medical claims and data analysis, and lending; and patent and intellectual property matters involving pharmaceutical drugs, petrochemical formulation, automobile components, intellectual property.Mr. Harvey has expertise in statistical and mathematical analysis of data. This expertise includes damage analysis; survey design, analysis and administration; U.S. and international payment card market analysis, profitability and forecasting; TV broadcast data analysis; human health and epidemiology involving tobacco risks, dynamic propagation of viruses, pharmaceutical drugs, and consumer products; automobile safety and valuation; hospital data analysis; class certification; evaluation of insurance claims including allocation among primary and excess insurance carriers; regression analysis; survival analysis; Bayesian analysis including imputation of missing data; propensity score analysis; conjoint analysis; forecasting; and big data analysis.